<DOC>
	<DOCNO>NCT00407745</DOCNO>
	<brief_summary>The purpose study evaluate pregabalin relief nerve pain associate spinal cord injury compare placebo ( pill contain active medicine ) . This study also evaluate safety pregabalin patient population .</brief_summary>
	<brief_title>A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects nerve pain Spinal cord injury ( traumatic , diving , ischemic removal benign tumor ( except meningioma fibroma ) Pain chronic ( continuous least 3 month intermittent least 6 month Pain score least 4 4 7 day prior receive treatment . Pregabalin use last 60 day , prior intolerance pregabalin Creatinine clearance &lt; 60 mL/min . White blood cell count &lt; 2500/mm3 ; neutrophil count &lt; 1500/mm3 ; platelet count &lt; 100 x 103/ mm3 . Abuse drug alcohol Unstable medial condition Clinically significant abnormal electrocardiogram ( ECG ) . Presence severe pain associated condition spinal cord injury could confound assessment selfevaluation pain due spinal cord injury .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>central neuropathic pain</keyword>
</DOC>